-
-
Fasting after 60 changes more than waistlines, exposing a trade-off many dieters never see coming
-
New AI tools could help eye doctors diagnose retinal disease faster
Dengue is no longer just a travel risk—what Google’s mosquito plan could mean for your summer
Visual AI tracks nearly 100 wildlife species to improve conservation
ADA: Obesity partners Zealand and Roche aim for weight loss ‘sweet spot’ with amylin agonist
In The News
- New AI tools could help eye doctors diagnose retinal disease faster June 06, 2026 By News Team
- Visual AI tracks nearly 100 wildlife species to improve conservation June 06, 2026 By News Team
- Lilly and Novo face off at ADA 2026 as others seek to compete in obesity June 06, 2026 By News Team
- Recordati fields $12.4B go-private offer May 25, 2026 By News Team
- Why energy fades with age: Missing membrane lipid may destabilize mitochondria May 22, 2026 By News Team
Biotechnology Daily
more-
Dengue is no longer just a travel risk—what Google’s mosquito plan could mean for your summer
This is not science fiction or some perverse prank. A Silicon Valley tech giant is…
Visual AI tracks nearly 100 wildlife species to improve conservation
Behind the FDA’s Breakthrough Therapy Designation and Its Billion-Dollar Impact on Biotech Portfolios
Inside the IND Filing Milestone Revolution Reshaping Modern Drug Development
Novel synthetic biomolecule degrades disease-related proteins
Market Watch
more-
Emerging Biotech Goldmine Transforms Rare Disease Treatment Into Billion-Dollar Ventures
The pharmaceutical landscape is witnessing an unprecedented transformation as rare disease treatments emerge as some…
Orphan Drug Status Designations Signal the Next Wave of Biotech Investment Opportunities
Market Signals Reveal the Hidden Forces Driving Biosimilar Competition Across Global Pharma
Biosimilar Competition Sends Biotech Giants Scrambling as Patent Cliffs Reshape Market Dynamics
Market Signals Every Biotech Investor Should Watch When Companies Secure Orphan Drug Status
Bio Business News
moreADA: Obesity partners Zealand and Roche aim for weight loss ‘sweet spot’ with amylin agonist
Analysts and investors were unimpressed by Phase 2 data posted…
Lilly and Novo face off at ADA 2026 as others seek to compete in obesity
The American Diabetes Association’s annual congress will feature a superstar…
Data Shows Biotechnology Royalty Streams Deliver Superior Returns for Passive Healthcare Investors
The pharmaceutical industry’s trillion-dollar market presents compelling investment prospects, yet…
World News
moreFasting after 60 changes more than waistlines, exposing a trade-off many dieters never see coming
Most folks know intermittent fasting helps with weight loss, usually…
New AI tools could help eye doctors diagnose retinal disease faster
Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath…
Breakthrough Clinical Milestones Drive Record Biotech Investment Returns Across Global Markets
The biotech investment landscape has undergone a dramatic transformation, with…
Emerging Biotech Goldmine Transforms Rare Disease Treatment Into Billion-Dollar Ventures
Fasting after 60 changes more than waistlines, exposing a trade-off many dieters never see coming
New AI tools could help eye doctors diagnose retinal disease faster
Dengue is no longer just a travel risk—what Google’s mosquito plan could mean for your summer
Visual AI tracks nearly 100 wildlife species to improve conservation
ADA: Obesity partners Zealand and Roche aim for weight loss ‘sweet spot’ with amylin agonist
Lilly and Novo face off at ADA 2026 as others seek to compete in obesity
Orphan Drug Status Designations Signal the Next Wave of Biotech Investment Opportunities
Data Shows Biotechnology Royalty Streams Deliver Superior Returns for Passive Healthcare Investors
Behind the FDA’s Breakthrough Therapy Designation and Its Billion-Dollar Impact on Biotech Portfolios